<VariationArchive VariationID="1050726" VariationName="NM_000251.3(MSH2):c.-1_211+1177del" VariationType="Deletion" Accession="VCV001050726" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2021-04-13" MostRecentSubmission="2023-09-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1037198" VariationID="1050726">
      <GeneList>
        <Gene Symbol="MSH2" FullName="mutS homolog 2" GeneID="4436" HGNC_ID="HGNC:7325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p21-16.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47403067" stop="47709830" display_start="47403067" display_stop="47709830" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="47630205" stop="47710366" display_start="47630205" display_stop="47710366" Strand="+" />
          </Location>
          <OMIM>609309</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MSH2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000251.3(MSH2):c.-1_211+1177del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="47403189" stop="47404577" display_start="47403189" display_stop="47404577" variantLength="1389" positionVCF="47403188" referenceAlleleVCF="CGACATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGTGAGGGCCGGGACGGCGCGTGCTGGGGAGGGACCCGGGGCCTTGTGGCGCGGCTCCTTTCCCGCCTCAGAGAGTGGGCGGTGAGCAGCCTCTCCAGTGCGGAGGCACGGGGGCGGAACGTTGGTGCTTGTGCGGATTCCGCCGTCCCCAGGTTCTGCTTGGCTCCGGAGGGACGCCCCCCTCAGCCCTGAAACCCGTGCCTCTCCAGCCGCCCCGGATCTGAACTTGTGATCACGGAGTGTTTACGTCGTGCCAGGCATTTTAATGCATTGTTCTAGTTCATTTTCCAGCAGTCGCATTCCTCGCCTTGGCCCTACATGTAGCGCTCATTACAAACACGGCCAGAATCTCTTATTAACAAACAGCAGCCAGGAGTGAGATTTAAAATAGACTGGGGGTTTAGGAGACCCTTTTATGACACGTAATTCTGCTCCCACGACGCTCCCATTTATACCGCCGGTCCAGCTAAGGGTCTGGTAATGGAGCGCCGTTGAAGAGCAGTATGATGAAGTGGTCAGGACCAACGGACTCTGGAGCTGGGCTGCTTGGGATCAAGTCGCTGCCCCTCTGCTTATTAACGTGTGACCTTGGGCCAGTCATGGACGCTATCTGCTTCAGCTCAGCATTCAGTGCTCTCCGTCACCCGACCCCATCTATCCAGGATTATCTCTCCCTGGAAAGCTACAAACGTCTCACCCTATGTGGGCCAAATGTTCTGGATAGGCCTAGTTAACCTCTTCTCTCCCTGTTTTCTTTGCGCTTTCTTGCAGCTATGTAGTTATGCTAATGAAAAGAGCATCCTAGGGGGAGCAGAGTTGTGGATTCTAGTCCTGACTAGAGGACTAGTGCAAATGCGATACTCCTGATGAAAAATGTTTCATTCGTTAGATATAAATGTGTTAGGCAGGGTTATGGACACTAGATGAAAAAAGAAATACCTCTACTTTCATAGAGATCACTATTGGACAGCAAGGCAGAAATAATTACAATTCAAGTTGGAGGCTTATGGAGGTGAGCTTGTAAGAGGTTACAAGAGGCGCCAAGGCAGGATCGCCAAAGACGGAAGACTTTGGAAGAGTCTCATACAACGGAAGAGGCGTTATATGAGACACCAAAGTCCACGTTGAGTCTTGGTGGACTAGAAGTTTGCTAGGGAGAGGGCTTGAAACGAGGTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="47630328" stop="47631716" display_start="47630328" display_stop="47631716" variantLength="1389" alternateAllele="-" positionVCF="47630327" referenceAlleleVCF="CGACATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGTGAGGGCCGGGACGGCGCGTGCTGGGGAGGGACCCGGGGCCTTGTGGCGCGGCTCCTTTCCCGCCTCAGAGAGTGGGCGGTGAGCAGCCTCTCCAGTGCGGAGGCACGGGGGCGGAACGTTGGTGCTTGTGCGGATTCCGCCGTCCCCAGGTTCTGCTTGGCTCCGGAGGGACGCCCCCCTCAGCCCTGAAACCCGTGCCTCTCCAGCCGCCCCGGATCTGAACTTGTGATCACGGAGTGTTTACGTCGTGCCAGGCATTTTAATGCATTGTTCTAGTTCATTTTCCAGCAGTCGCATTCCTCGCCTTGGCCCTACATGTAGCGCTCATTACAAACACGGCCAGAATCTCTTATTAACAAACAGCAGCCAGGAGTGAGATTTAAAATAGACTGGGGGTTTAGGAGACCCTTTTATGACACGTAATTCTGCTCCCACGACGCTCCCATTTATACCGCCGGTCCAGCTAAGGGTCTGGTAATGGAGCGCCGTTGAAGAGCAGTATGATGAAGTGGTCAGGACCAACGGACTCTGGAGCTGGGCTGCTTGGGATCAAGTCGCTGCCCCTCTGCTTATTAACGTGTGACCTTGGGCCAGTCATGGACGCTATCTGCTTCAGCTCAGCATTCAGTGCTCTCCGTCACCCGACCCCATCTATCCAGGATTATCTCTCCCTGGAAAGCTACAAACGTCTCACCCTATGTGGGCCAAATGTTCTGGATAGGCCTAGTTAACCTCTTCTCTCCCTGTTTTCTTTGCGCTTTCTTGCAGCTATGTAGTTATGCTAATGAAAAGAGCATCCTAGGGGGAGCAGAGTTGTGGATTCTAGTCCTGACTAGAGGACTAGTGCAAATGCGATACTCCTGATGAAAAATGTTTCATTCGTTAGATATAAATGTGTTAGGCAGGGTTATGGACACTAGATGAAAAAAGAAATACCTCTACTTTCATAGAGATCACTATTGGACAGCAAGGCAGAAATAATTACAATTCAAGTTGGAGGCTTATGGAGGTGAGCTTGTAAGAGGTTACAAGAGGCGCCAAGGCAGGATCGCCAAAGACGGAAGACTTTGGAAGAGTCTCATACAACGGAAGAGGCGTTATATGAGACACCAAAGTCCACGTTGAGTCTTGGTGGACTAGAAGTTTGCTAGGGAGAGGGCTTGAAACGAGGTA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.47630330_47631718del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.47630330_47631718del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.47403191_47404579del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.47403191_47404579del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007110.2" sequenceAccession="NG_007110" sequenceVersion="2" change="g.5068_6456del">
            <Expression>NG_007110.2:g.5068_6456del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258281.1" sequenceAccession="NM_001258281" sequenceVersion="1" change="c.-31+16_13+1177del">
            <Expression>NM_001258281.1:c.-31+16_13+1177del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000251.3" sequenceAccession="NM_000251" sequenceVersion="3" change="c.-1_211+1177del" MANESelect="true">
            <Expression>NM_000251.3:c.-1_211+1177del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_218" sequenceAccession="LRG_218">
            <Expression>LRG_218:g.5068_6456del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000251.3(MSH2):c.-1_211+1177del AND Carcinoma of colon" Accession="RCV001358512" Version="2">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-04-13" MostRecentSubmission="2023-09-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3055525" SubmissionDate="2021-03-31" DateLastUpdated="2023-09-03" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr2:47630328-47631717:c2e2212de555b215b3ec8043ae827114-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001554266" DateUpdated="2023-09-03" DateCreated="2021-04-13" Type="SCV" Version="2" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MSH2, c.1-?_1386+?del variant (chr:2 g.47630331_47672796del GRCh37) results in a deletion of exons 1 to 8, although the precise breakpoints of this deletion were not determined, nor were the effects of this variant on the resulting mRNA or protein product determined. The variant was identified in 19 of 3718 proband chromosomes (frequency: 0.005) from individuals or families with Lynch syndrome (Ainsworth 2004, Baudhuin 2005, Baudhuin 2005, Bunyan 2004, Charbonnier 2005, De Lellis 2006, Lagerstedt-Robinson 2016, Pastrello 2006, Pistorius 2007, Spaepen 2006, Taylor 2003). The variant was also identified in ClinVar (reported as c.(?_-68)_1386+?del and classified as pathogenic by InSight), and in Mismatch Repair Genes Variant Database. The variant was not identified in dbSNP, COGR, UMD-LSDB, Zhejiang University Database, or Insight Hereditary Tumors Database. The variant was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). This alteration is predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the MSH2 gene are an established mechanism of disease in Lynch syndrome and this is the type of variant expected to cause the disorder. In summary, based on the above information this variant meets our laboratoryâ€šÃ„Ã´s criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MSH2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="-" start="47630329" stop="47631717" variantLength="1389" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3055525" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

